Abstract
Objective
To determine whether 3-monthly supplementation of an oral vitamin D widely used in Spain (calcifediol) plus daily exercise could influence survival at one and four years after surgery for osteoporotic hip fracture.
Design
A pragmatic, randomized, partially single-blind placebo-controlled study.
Setting
Patients admitted to a tertiary university hospital for acute hip fracture.
Participants
675 healthy adult patients undergoing surgery for osteoporotic hip fracture were recruited from January 2004 to December 2007.
Intervention
Patients were randomized to receive either 3-monthly oral doses of 3 mg calcifediol (Hidroferol Choque®) or placebo in the 12 months postsurgery. Patients who received calcifediol were also given an exercise programme. The placebo group received standard health recommendations only.
Measurements
The primary endpoint was survival at 1 year and at 4 year follow-up. We also recorded new fractures, medical complications and anti-osteoporotic treatment compliance.
Results
We included a total of 88 patients, aged 62 to 99 years. Mean age was 82 years and 88.6% were women. At 12 months, 10 (11.3%) patients had died, 9 of them, from the non-intervention group. At 4 years after surgery, 20 (22.7%) had died, 3 (3.4%) from the intervention group and 17 (19.3%) from the non-intervention group. At this time, survival curve analysis showed 93% survival in the intervention group and 62% in the non-intervention group (p=0.001). At 12-month follow up, there were 18 new fractures, 9 in each group. The non-intervention group had more medical complications, with significant differences at visit 2 (p = 0.04) and 3 (p = 0.02) but not at visit 4 (p = 0.18). No significant differences between groups were found regarding treatment compliance.
Conclusion
3-monthly, oral supplements of 3 mg calcifediol plus daily exercise improved survival at one-year and four-year follow up after surgery for an osteoporotic hip fracture.
Similar content being viewed by others
Abbreviations
- IG:
-
intervention group
- NIG:
-
non-intervention group
- SD:
-
standard desviation
- PTH:
-
parathormone
- AST:
-
aspartate aminotransferase
- ALT:
-
alanine aminotransferase
- GGT:
-
gammaglutamyltransferase
- AP:
-
alkaline phosphatase
References
Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, et al. Swedish Hip Fracture Study Group. Survival after hip fracture. Osteoporos Int 2005; 16: 1583–90.
Jiang HX, Majumdar SR, Dick DA, Moreau M, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 2005; 20: 494–500.
Lee AY, Chua BS, Howe TS. One-year outcome of hip fracture patients admitted to a Singapore hospital:quality of life post-treatment. Singapore Med J 2007; 48: 996–9.
Peterson MG, Cornell CN, Paget SA, Allegrante JP. Five-year survival in a cohort of hip fracture patients: the predictive role of pre-fracture health status. HSS J 2008; 4: 43–7.
Paksima N, Koval KJ, Aharanoff G, Walsh M, et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis 2008; 66: 111–7.
Maggi S, Siviero P, Wetle T, Besdine RW, et al. A multicenter survey on profile of care for hip fracture: predictors of mortality and disability. Osteoporos Int 2009; 21: 223–31.
Vaseenon T, Luevitoonvechkij S, Wongtriratanachai P, Rojanasthien S. Long-term mortality after osteoporotic hip fracture in Chiang Mai, Thailand. J Clin Densitom 2010; 13: 63–7.
Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010; 39: 203–9.
Haentjens P, Magaziner J, Colon-Emeric CS, Vanderschueren D, et al. Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 2010; 152: 380–90.
Kreutzfeldt J, Haim M, Bach E. Hip fracture among the elderly in a mixed urban and rural population. Age Ageing 1984; 13: 111–9.
Richmond J, Aharonoff GB, Zuckerman JD, Koval KJ. Mortality risk after hip fracture. J Orthop Trauma 2003;17 Suppl 8:S2–5.
Parker MJ, Pryor GA, Myles J. 11-year results in 2,846 patients of the Peterborough Hip Fracture Project: reduced morbidity, mortality and hospital stay. Acta Orthop Scand 2000; 71: 34–8.
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.
Larrosa M, Gratacos J, Vaqueiro M, Prat M, et al. Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc) 2001; 117: 611–4.
Vaqueiro M, Bare M, Anton E, Andreu E, et al. Hypovitaminosis D associated to low sun exposure in the population over 64 years old. Med Clin (Barc) 2007; 129: 287–91.
Bruyere O, Decock C, Delhez M, Collette J, et al. Highest prevalence of vitamin D inadequacy in institutionalized women compared with noninstitutionalized women: a case-control study. Womens Health (Lond Engl) 2009; 5: 49–54.
Kanis JA, Burlet N, Cooper C, Delmas PD, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399–428.
Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551–61.
Bunout D, Barrera G, Leiva L, Gattas V, et al. Effects of vitamin D supplementation and exercise training on physical performance in chilean vitamin D deficient elderly subjects. Exp gerontol 2006; 41: 746–52.
Dhesi JK, Jackson SH, Bearne LM, Moniz C, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004; 33: 589–95.
Houston DK, Cesari M, Ferrucci L, Cherubini A, et al. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007; 62: 440–6.
Stewart JW, Alekel DL, Ritland LM, Van Loan M, et al. Serum 25-hydroxyvitamin D is related to indicators of overall physical fitness in healthy postmenopausal women. Menopause 2009; 16: 1093–101.
Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; CD007146.
Zhu K, Devine A, Dick IM, Wilson SG, et al. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab 2008; 93: 743–9.
Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004; 80: 752–8.
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014; CD007470.
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J of Clin Nutr 2008;87:1080S–6S.
Holick MF, Siris ES, Binkley N, Beard MK, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215–24.
Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151–4.
Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clinical Densitom 2011; 14: 79–84.
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815–22.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
Lips P, Binkley N, Pfeifer M, Recker R, et al. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J of Clin Nutr 2010; 91: 985–91.
Avenell A, Grant AM, McGee M, McPherson G, et al. The effects of an open design on trial participant recruitment, compliance and retention—a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin Trials 2004; 1: 490–8.
Harwood RH, Sahota O, Gaynor K, Masud T, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham neck of femur (NONOF) Study. Age Ageing 2004; 33: 45–51.
Smith H, Anderson F, Raphael H, Maslin P, et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007; 46: 1852–7.
Sato Y, Iwamoto J, Honda Y. An open-label trial comparing alendronate and alphacalcidol in reducing falls and hip fractures in disabled stroke patients. J Stroke Cerebrovasc Dis 2011; 20: 41–6.
Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J of Steroid Biochem Mol Biol 2004;89-90:497–501.
Ivorra J, Valls E, Fernández-Llanio Comella N, Chalmeta Verdejo I, et al. Monitorización de los valores séricos de vitamina D en mujeres con osteoporosis posmenopáusica tratadas con dosis habituales de vitamina D. Med Clin (Barc) 2012; 138: 199–201.
Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 1988; 10: 64–7.
Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136–9.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83.
Bliuc D, Nguyen ND, Milch VE, Nguyen TV, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009; 301: 513–21.
Morin S, Lix LM, Azimaee M, Metge C, et al. Mortality rates after incident nontraumatic fractures in older men and women. Osteoporos Int 2011; 22: 2439–48.
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83: 754–9.
Oliai Araghi S, van Dijk SC, Ham AC, Brouwer-Brolsma EM, et al. BMI and Body Fat Mass Is Inversely Associated with Vitamin D Levels in Older Individuals. J Nutr Health Aging 2015; 10: 980–5.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–56.
Grant AM, Avenell A, Campbell MK, McDonald AM, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium or vitamin D, RECORD): a randomised placebocontrolled trial. Lancet 2005; 365: 1621–8.
Bischoff-Ferrari HA, Dawson-Hughes B, Platz A, Orav EJ, et al. Effect of highdosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch Intern Med 2010; 170: 813–20.
Langsetmo L, Barr SI, Berger C, Kreiger N, et al. Associations of Protein Intake and Protein Source with Bone Mineral Density and Fracture Risk: A Population-Based Cohort Study. J Nutr Health Aging. 2015; 19: 861–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laiz, A., Malouf, J., Marin, A. et al. Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: A pragmatic randomized, partially blinded, controlled trial. J Nutr Health Aging 21, 413–420 (2017). https://doi.org/10.1007/s12603-016-0773-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-016-0773-3